According to The Cancer Genome Atlas (TCGA) online dataset [22], low expression levels of ALCAM correlate with shorter overall survival of glioblastoma patients (n = 504; average cut-off = 590.3; p = 5.2e−03) (Figure S4A). The gene discussed is ALCAM; the disease is glioblastoma.